Results for tag: "Intra Dialytic Hypotension Drug"

Intra Dialytic Hypotension (IDH) is a type of hypotension that occurs during hemodialysis, a procedure used to treat patients with kidney failure. IDH is caused by a decrease in blood pressure due to the rapid removal of fluid from the body during dialysis. It can lead to a variety of symptoms, including dizziness, fatigue, and nausea. Treatment of IDH typically involves the use of cardiovascular drugs, such as vasopressors, diuretics, and calcium channel blockers. These drugs are used to increase blood pressure and reduce the risk of complications associated with IDH. The Intra Dialytic Hypotension Drug market is a subset of the larger Cardiovascular Drugs market. It is composed of drugs used to treat IDH, such as vasopressors, diuretics, and calcium channel blockers. These drugs are used to increase blood pressure and reduce the risk of complications associated with IDH. Some companies in the Intra Dialytic Hypotension Drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more